zoledronic acid has been researched along with FMR1-Related Primary Ovarian Insufficiency in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albert, U; Hadji, P; Kalder, M; Maskow, C; Ziller, M | 1 |
Archer, L; Burstein, HJ; Halabi, S; Hars, V; Hudis, C; Isaacs, C; Kirshner, J; Paskett, E; Schilsky, R; Shapiro, CL; Sikov, W; Weckstein, D; Winer, E | 1 |
2 trial(s) available for zoledronic acid and FMR1-Related Primary Ovarian Insufficiency
Article | Year |
---|---|
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.
Topics: Adult; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Fatigue; Female; Fever; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Pain; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Zoledronic Acid | 2011 |
CALGB 78909: Phase III trial of intravenous zoledronic acid in the prevention of bone loss in localized breast cancer patients with chemotherapy-induced ovarian failure.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Resorption; Breast Neoplasms; Clinical Protocols; Diphosphonates; Drug Administration Schedule; Female; Humans; Imidazoles; Infusions, Intravenous; Primary Ovarian Insufficiency; Randomized Controlled Trials as Topic; Zoledronic Acid | 2005 |
1 other study(ies) available for zoledronic acid and FMR1-Related Primary Ovarian Insufficiency
Article | Year |
---|---|
The influence of chemotherapy on bone mineral density, quantitative ultrasonometry and bone turnover in pre-menopausal women with breast cancer.
Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Breast Neoplasms; Calcaneus; Case-Control Studies; Cyclophosphamide; Diphosphonates; Doxorubicin; Female; Hip; Humans; Imidazoles; Lumbar Vertebrae; Middle Aged; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Statistics, Nonparametric; Time Factors; Ultrasonography; Young Adult; Zoledronic Acid | 2009 |